Gitnux/Report 2026

Fertility Clinic Industry Statistics

U.S. survey data finds 3.7% of adults have been told they were infertile—explore what this means for fertility clinic demand.
274Statistics
67Sources
12Sections
1Visuals
48mRead
November 11, 2026Updated
Fertility Clinic Industry Statistics
Min-ji ParkWritten by Min-ji Park·Edited by Marcus Engström·Fact-checked by Olivia Thornton
Published ·Updated
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 31 days

01 Industry overview

The fertility clinic industry at a glance

The fertility clinic industry is expanding as IVF, fertility preservation and donor services gain use: the global fertility services market reached $42.2 billion in 2023 and is forecast to grow at 7.5% annually through 2030.

$42.2B[55]
Global market size, 2023
7.5%[55]
Forecast CAGR, 2024–2030
435,426[17]
U.S. ART cycles, 2022
2.6%[17]
U.S. births from ART, 2022
Market size
The global fertility services market was valued at $42.2 billion in 2023. Grand View Research projects it to reach $52.7 billion in 2026 and $70.3 billion in 2030.[55]
Forecast & CAGR
The market is projected to grow at a 7.5% compound annual growth rate from 2024 to 2030. Growth is linked to increased use of IVF, fertility preservation, preimplantation genetic testing and digital fertility services.[55]
Market share & regions
North America is identified as a leading regional market in the global fertility services industry. In the United States, 457 clinics reported ART activity in 2022, while the UK recorded approximately 98,900 treatment and storage cycles in 2023.[55][17][31]
Segmentation
In the UK, IVF represented 78% of approximately 98,900 treatment and storage cycles in 2023, followed by embryo storage at 9%, egg freezing at 7% and donor insemination at 6%. U.S. ART activity also includes fresh and frozen embryo transfers, donor cycles and egg or embryo banking.[31][17]
Pricing
U.S. IVF pricing varies substantially by clinic and by what is included. Published estimates commonly place one IVF cycle, including clinic procedures, medications and genetic testing, at approximately $15,000 to $30,000, while the Federal Register cites an average cost range of $12,000 to $25,000 per cycle.[56][57]
Trends, drivers & challenges
Demand is being supported by increased fertility preservation and frozen-embryo treatment: UK egg-freezing cycles rose from 2,567 in 2019 to 6,932 in 2023, a 170% increase, while frozen embryo-transfer cycles rose 24%. High treatment costs and uneven insurance coverage remain major access constraints; ASRM reported that 22 U.S. states had infertility-insurance mandates in 2025, with varying scope.[31]
Consumer behavior & competition
U.S. ART patients averaged 36.3 years of age in 2022, and 37.5% of ART cycles resulted in a live-birth delivery. In the UK, single-embryo transfer and frozen treatment have become increasingly common, while patients compare clinics using age-specific birth rates and treatment outcomes.[17][31]
Regulation
U.S. ART clinics are subject to the Fertility Clinic Success Rate and Certification Act of 1992 and must report standardized treatment and outcome data to the CDC. In the UK, fertility clinics must be licensed and regulated by the HFEA; the regulator reported more than 100,000 treatment, storage or donation cycles in UK clinics in 2024–25.[17][31]
Latest news
Recent industry developments include continued expansion of frozen-embryo treatment and fertility preservation. HFEA data show UK egg-freezing cycles increased 170% between 2019 and 2023, while its 2024–25 sector update reported more than 100,000 treatment, storage or donation cycles in UK clinics.[31]

02 Ranking

Top 10 Companies in the Fertility Clinic Industry

The leading companies in the fertility clinic industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 11, 2026 · Next review December 11, 2026

Verdict

US Fertility leads Gitnux's 2026 fertility clinic ranking with an Overall score of 9.8, with more than 135 clinic locations and 32 IVF laboratories. FutureLife is the runner-up at 9.5, backed by over 60 clinics in 15 European countries.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in IVF & fertility services

    US Fertility

    US

    Ranked #1 · 9.8 · IVF & fertility services

    Why we picked it: It supports physician-owned fertility practices and IVF laboratories across the United States footprint.

    See in ranking ↓Visit usfertility.com ↗

  2. #2 overall

    FutureLife

    CZ

    Ranked #2 · 9.5 · IVF & fertility services

    Why we picked it: It runs fertility clinics and reproductive genetics across Europe, with 77,000+ treatment cycles.

    See in ranking ↓Visit futurelifegroup.com ↗

  3. #3 overall

    IVIRMA Global

    ES

    Ranked #3 · 9.1 · IVF & fertility services

    Why we picked it: It operates a multi-country set of fertility clinics and laboratories for assisted reproduction services.

    See in ranking ↓Visit ivirma.com ↗

Pick 1 is the #1 company overall. No other segment places in the top 5, so picks 2 and 3 follow rank.

Full ranking

Sort by
Top 10 companies in the fertility clinic industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

US Fertility

IVF & fertility services · US

9.8
2

FutureLife

IVF & fertility services · CZ

9.5
3

IVIRMA Global

IVF & fertility services · ES

9.1
4

Virtus Health

IVF & fertility services · AU

8.6
5

The Fertility Partners

IVF & fertility services · CA

8.4
6

Eugin Group

Assisted reproduction clinics in Europe and South America · ES

8.2
7

Nova IVF Fertility

Single-specialty IVF and fertility clinics across India · IN

8.1
8

Birla Fertility & IVF

IVF and fertility clinics across India · IN

8.0
9

Monash IVF Group

Fertility clinics, genetics and reproductive services in Australia · AU

7.8
10

Indira IVF

IVF and fertility clinics across India · IN

7.7

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 11, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Min-ji Park. (2026, February 13). Top 10 companies in the fertility clinic industry. In Fertility Clinic Industry Statistics. Gitnux. https://gitnux.org/fertility-clinic-industry-statistics/#top-companies

report visual · Projection

Number of ART egg or embryo banking cycles performed at reporting fertility clinics (United States)

Number of ART egg or embryo banking cycles performed at reporting fertility clinics grew from 88K in 2017 to 184K in 2022.

87.9K count
Start
+15.97%
CAGR · 5y
184.4K count
Projected
20172022
source-verifiedcdc.gov2022

04 Statistics

Technology & Innovation

AI adoption shows up across lab, pretreatment, and administrative workflows, with 74.9% of surveyed clinics reporting AI use in embryology laboratories. The section also highlights automation research and readiness for IVF AI applications.

AI in the fertility clinic industry

  • 74.9% of surveyed fertility clinics reported AI use in embryology laboratories, including time-lapse imaging and embryo selection.[1]
  • 24.8% of surveyed fertility clinics reported using generative AI.[1]
  • 75.4% of surveyed fertility clinics reported AI use in pretreatment activities.[1]
  • 64.1% of surveyed fertility clinics reported AI use in administrative activities.[1]
  • 15 U.S. fertility clinics were using Alife Health AI software in 2023.[2]
  • 40.7% of surveyed fertility clinics reported AI use in ovarian-stimulation activities.[1]

Automation in the fertility clinic industry

  • 1 integrated end-to-end laboratory automation study had produced peer-reviewed clinical evidence by 2026.[3]
  • 3 laboratory task areas—embryo selection, vitrification and warming, and ICSI—have been principal targets of IVF automation research.[3]
  • 80 companies were counted as making or selling devices to IVF laboratories and fertility clinics in 2026.[4]
  • 1,066 women across 14 IVF clinics in Australia and Europe were randomized to AI embryo selection or standard morphology selection.[5]
  • 1 randomized multicenter trial found a closed semi-automated vitrification platform clinically equivalent to manual Cryotop vitrification.[3]
  • 5% was the non-inferiority margin used in the randomized AI embryo-selection trial across 14 IVF clinics.[5]

Digital Transformation in the healthcare services sector (sector benchmark)

  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[6]
  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[7]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[6]
  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[8]
  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[9]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[7]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[10]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 48% used social-media data in 2024.[11]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 77% used in-house staff rather than external providers in 2024.[11]

05 Statistics

Data & Analytics

This section quantifies the data lift clinics seek from AI, including reduced errors at 48.3% and improved scheduling at 46.3%. It also reports registry friction from inaccurate or incomplete manual data.

Business intelligence in the fertility clinic industry

  • 46.3% of fertility-clinic respondents reported improved scheduling as a benefit of AI and digital technologies in IVF.[1]
  • 51.0% of fertility-clinic respondents reported improved communication as a benefit of AI and digital technologies in IVF.[1]
  • 48.3% of fertility-clinic respondents reported reduced errors as a benefit of AI and digital technologies in IVF.[1]
  • 75.2% of surveyed international IVF specialists reported not using AI-based IVF software in 2022.[12]
  • 53.1% of fertility-clinic respondents reported better data management as a benefit of AI and digital technologies in IVF.[1]
  • 48.3% of fertility-clinic respondents reported increased patient satisfaction as a benefit of AI and digital technologies in IVF.[1]

Data analytics in the fertility clinic industry

  • 61 embryologists from 12 IVF clinics participated in a survey-based study of AI-assisted embryo ranking.[13]
  • 14,644 embryos with known implantation outcomes were included in the AI embryo-selection model’s evaluation dataset.[14]
  • 10 IVF clinics across 9 countries contributed data to a multicenter AI embryo-evaluation validation study.[13]
  • 1,066 women across 14 IVF clinics were randomized in a study comparing AI-assisted and standard embryo selection.[5]
  • 208 seconds per embryo was the approximate manual assessment time reported in an IVF automation study.[5]
  • 0.60–0.75 was the clinic-holdout AUC range for an AI model predicting implantation from embryo images across new IVF clinics.[14]

Data Quality in the healthcare services sector (sector benchmark)

  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[15]
  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[16]
  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[15]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[15]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[15]

Data Governance in the healthcare services sector (sector benchmark)

  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[16]
  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[16]
  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[16]
  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[16]
  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[16]
  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[16]

KPIs in the fertility clinic industry

  • 2.6% of U.S. infants born in 2022 were represented by live-born infants resulting from ART cycles reported by fertility clinics.[17]
  • 5 points were used to score IVF clinical and laboratory indicators in an Italian KPI consensus framework.[3]
  • 98,289 live-born infants were recorded as an ART outcome at U.S. fertility clinics in 2022.[17]
  • 457 U.S. fertility clinics reported ART activity to the CDC for 2022.[17]
  • 251,542 unique patients were included in the CDC’s 2022 national ART surveillance figures.[17]
  • 94,039 live-birth deliveries were recorded as an ART outcome at U.S. fertility clinics in 2022.[17]

06 Statistics

Strategy & Growth

This section links chain affiliation to higher volumes and outcomes in the U.S. study period, including a 27.2% IVF-cycle volume increase after joining a chain. It also flags acquisition activity and partnership-driven investment.

Growth in the fertility clinic industry

  • The share of U.S. fertility clinics in a chain increased from 5% in 2004 to 20% in 2018.[18]
  • Acquired fertility clinics increased IVF-cycle volume by 27.2% after joining a chain, according to a U.S. study covering 2004–2018.[18]
  • The U.S. fertility-clinic market grew by approximately 35 clinical locations, from 485 in 2024 to 520 in September 2026.[19]
  • Acquired clinics increased live-birth rates by 13.6% after chain ownership in the U.S. study.[18]
  • Acquired clinics were estimated to increase average annual pre-tax profit from 2.4 million dollars to 3.2 million dollars, a 33% increase.[18]
  • Chain-affiliated clinics performed more than 40% of U.S. IVF cycles by 2018.[18]

Differentiation in the fertility clinic industry

  • 50% was the reported increase in Kindbody egg-freezing cycles between April 2023 and April 2024.[2]
  • 17,702 IVF/ICSI cycles across nine UK clinics formed the dataset for a study examining race and ethnicity reporting in fertility medicine.[20]
  • 13.6% was the relative live-birth-rate improvement associated with acquired-chain clinics compared with controls in a U.S. study.[18]
  • 5.1 percentage points was the observed live-birth-rate increase after fertility-clinic acquisition in the same U.S. study.[18]

Mergers and acquisitions in the fertility clinic industry

  • Only three U.S. fertility clinics had been purchased by networks in 2025 as of October 24, according to Inside Reproductive Health reporting.[21]
  • 21 existing U.S. fertility centers, roughly 4% of the market, changed ownership during the 2024–2026 study window.[19]
  • 41 reproductive-health buyouts totaling 8.4 billion dollars were identified in 2026’s global private-equity investment review.[19]
  • 14 independent U.S. fertility clinics were acquired by networks during the 2024–2026 study period.[19]
  • IVI-RMA Global’s reported acquisition of ART Fertility Clinics was valued at approximately 400–450 million dollars in 2025.[4]

Strategic partnerships in the fertility clinic industry

  • Chain affiliation increased IVF-cycle volume by more than 25% in the U.S. study, although the significant live-birth-rate improvement was limited to acquired clinics.[18]
  • A 2026 partnership between FutureLife and Alife Health expanded the group’s investment in artificial-intelligence-enabled reproductive medicine.[4]
  • More than 650 clinics and over 1,000 providers partnered with Progyny in its U.S. fertility-benefits network in 2024.[22]
  • A partnership between Walmart and its fertility-benefits provider gave employees access to more than 30 fertility clinics and IVF laboratories in 2022.[2]
  • U.S. fertility chains can grow through affiliation as well as acquisition or new-clinic construction, according to a 2004–2018 industry study.[18]

07 Statistics

People & Workforce

Workforce constraints appear as a persistent operational risk, with 72% of IVF laboratory directors reporting difficulty filling open positions. Staffing levels were also insufficient for optimal workload distribution in 68% of responses.

Hiring in the fertility clinic industry

  • 0.19% of the U.S. industry job market was estimated to comprise professional embryologists in 2022.[23]
  • 72% of IVF laboratory directors globally reported difficulty filling open positions in a survey cited in a 2025 review.[5]
  • 68% of IVF laboratory directors globally reported staffing levels were insufficient for optimal workload distribution.[5]

Employee retention in the fertility clinic industry

  • 48.1% of Spanish embryologists reported high depersonalization in a national assisted-reproduction workforce survey.[24]
  • 45.3% of Spanish embryologists reported musculoskeletal disorders in a workforce-stress study.[5]
  • 27.8% of Spanish embryologists reported stress and mental-health problems in a workforce-stress study.[5]
  • 72.1% of Spanish embryologists reported high emotional exhaustion in a national assisted-reproduction workforce survey.[24]
  • 48.1% of Spanish embryologists reported low personal accomplishment in a national assisted-reproduction workforce survey.[24]

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[25]
  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[26]
  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[25]
  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[25]

Hybrid Work in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[25]
  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[25]
  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[25]
  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[26]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[25]

Upskilling in the fertility clinic industry

  • 4 WHO regions were compared in a worldwide study of burnout among assisted-reproduction embryologists.[5]
  • 83% of UK embryologists in a comparative workforce survey held a graduate degree.[27]
  • 1 international framing paper called for harmonized education and training standards for clinical embryologists.[3]
  • 5 world regions were represented in the qualitative expert panel underpinning a global embryologist workforce study.[28]

Employee Engagement in the healthcare services sector (sector benchmark)

  • Across 2.3 million U.S. healthcare workers, employee engagement declined by 0.02 points in 2024.[29]
  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[29]
  • Across U.S. healthcare workers, 78% believed their organization cared about their safety in 2024.[29]
  • Among U.S. healthcare advanced practice providers, 52% felt heard in 2024.[29]
  • U.S. registered nurses with low teamwork scores were 1.53 times more likely to leave their healthcare organization in 2024.[29]

Change Management in the healthcare services sector (sector benchmark)

  • Across 36 healthcare transformation studies, 64% reported successful transformation, 6% reported partial success, and 17% reported unsuccessful transformation.[30]
  • Among 31 healthcare transformation studies excluding varied-success comparisons, 74% reported full success.[30]
  • Among United Kingdom healthcare transformation studies, 67% reported successful transformation.[30]
  • Across healthcare transformation studies using staff surveys, 78% reported successful transformation and 83% reported either success or partial success.[30]

08 Statistics

Customer & Sales

Patient communications and follow-up pathways are treated as measurable levers, including a 41% return rate after compassionate reminder emails in a U.S. study. Social and web channels show distinct preferences by time spent online.

Customer experience in the fertility clinic industry

  • 66% of Asian and Black UK fertility patients were satisfied with the quality of information received, compared with 78% overall, in 2024.[31]
  • 75% of UK fertility-clinic users were satisfied with fertility treatment overall in 2018, while 30% of unsuccessful patients were dissatisfied.[31]
  • 79.9% of 219 infertility patients said social media benefited their fertility-clinic patient experience in the United States in 2018.[5]
  • 43% of UK fertility patients were satisfied with their experience speaking to a general practitioner about fertility options in 2024.[31]
  • 96.2% of 183 infertility patients felt comfortable communicating electronically with their fertility clinic in the United States in 2018.[5]

Customer retention in the fertility clinic industry

  • 30.68% of 3,214 couples did not return after their first fertility-center consultation in Italy in 2021.[32]
  • 31% of respondents in the U.S. follow-up-email study made a follow-up appointment after being contacted by the clinic.[20]
  • 18.71% of Italian couples who did not return after an initial fertility consultation transferred treatment to another center during 2012–2021.[32]
  • 41% of fertility patients who received a follow-up email returned to care, compared with 32% without an email, in a U.S. clinic study.[20]
  • 75.08% of 24,772 couples returned to a fertility center after their first consultation during 2012–2021 in Italy.[32]

Customer acquisition in the fertility clinic industry

  • YouTube was preferred by 59.46% of respondents spending one to three hours daily on social media when considering fertility treatment in the United States in 2024.[5]
  • YouTube was preferred by 70% of respondents spending more than three hours daily on social media when considering fertility treatment in the United States in 2024.[5]
  • 56% of 372 fertility-clinic websites posted success rates on their home pages in a U.S. website study published in 2012.[33]
  • YouTube was preferred by 40.22% of respondents spending under one hour daily on social media when considering a fertility provider in the United States in 2024.[5]
  • 67.76% of surveyed respondents said they would join an infertility support group in a U.S. study of social media and provider choice in 2024.[5]

Lead generation in the fertility clinic industry

  • Cost per lead decreased 24% after a paid-social growth program for a New York fertility clinic in 2026.[34]
  • The qualified pipeline increased 51% after a paid-social growth program for a New York fertility clinic in 2026.[34]
  • Fertility consultation requests increased 170%, from 39 to 105 per month, after a paid-social growth program for a New York fertility clinic in 2026.[34]
  • The conversion rate increased 65% after a paid-social growth program for a New York fertility clinic in 2026.[34]

09 Statistics

Marketing & Brand

Online reputation and website content are quantified, including a weighted average Google rating of 4.20 stars across 671 practices in 2026. It also documents FTC guideline adherence and the share with low ratings.

Digital marketing in the fertility clinic industry

  • 96% of U.S. fertility practices had a unique active website in a 2018 study of fertility-practice digital presence.[20]
  • 93% of U.S. fertility practices made no website claims of superiority over other practices in a 2018 study.[20]
  • 95% of U.S. fertility practices did not use SART data to compare themselves with other practices in a 2018 study.[20]
  • 77% of U.S. fertility practices followed Federal Trade Commission advertising guidelines in a 2018 website study.[20]

Branding in the fertility clinic industry

  • 35.6% of 671 U.S. fertility practices had Google ratings below four stars in 2026.[4]
  • More than 63,500 patient reviews were analyzed in a 2026 benchmark of U.S. fertility-practice online reputation.[4]
  • The weighted average Google rating was 4.20 stars across 671 fertility practices in 25 U.S. states in 2026.[4]

Social media in the fertility clinic industry

  • 58.97% of respondents spending one to three hours daily on social media preferred Facebook for an infertility support group in a U.S. study in 2024.[5]
  • 47.90% of respondents spending under one hour daily on social media preferred Facebook for an infertility support group in a U.S. study in 2024.[5]
  • 51.72% of respondents spending more than three hours daily on social media preferred Facebook for an infertility support group in a U.S. study in 2024.[5]
  • 25.21% of respondents spending under one hour daily on social media preferred Instagram for an infertility support group in a U.S. study in 2024.[5]
  • 7.7% of 183 infertility patients reported privacy concerns that prevented electronic communication with their fertility doctor in a U.S. study published in 2018.[5]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 33% of U.S.-focused health and wellness influencers promoted a product, service or subscription in more than half of their posts in 2026.[35]
  • 50% of U.S. physicians surveyed had changed prescribing choices based on healthcare influencer or KOL content on social media in 2024.[36]
  • 38% of posts from U.S.-focused health and wellness influencers promoted a product, service or subscription in 2026.[35]
  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[37]
  • 92% of U.S.-focused health and wellness influencers included product or service promotions at least occasionally in 2026.[35]

10 Statistics

Operations & Execution

Inspection and incident reporting provide a compliance view, including 104 inspections completed by UK regulators in 2023/24. The section also reports cycle throughput benchmarks and cancellation rates from consistently high-performing U.S. clinics.

Process optimization in the fertility clinic industry

  • 104 inspections were completed by UK fertility regulators in 2023/24, including five additional inspections prompted by concerns or reported incidents.[31]
  • 687 fresh retrieval cycles was the average annual volume per clinic among 13 consistently high-performing U.S. clinics in 2017.[38]
  • 6% was the average cycle-cancellation rate among 13 consistently high-performing U.S. IVF clinics in 2017.[38]
  • 11 of 13 consistently high-performing U.S. clinics had an onsite laboratory director in 2017.[38]
  • 1,472 total ART cycles was the average annual volume per clinic among 13 consistently high-performing U.S. clinics in 2017.[38]

Operational efficiency in the fertility clinic industry

  • 98,289 live-born infants resulted from ART cycles at reporting U.S. clinics in 2022.[17]
  • 184,423 U.S. ART cycles were egg- or embryo-banking cycles in 2022.[17]
  • 2.6% of all U.S. infants born in 2022 were represented by infants from reported ART cycles.[17]
  • 167,689 U.S. embryo-banking cycles were recorded in 2021, up from 18,585 in 2012.[32]
  • 251,542 unique patients received ART at reporting U.S. clinics in 2022.[17]

Quality management in the fertility clinic industry

  • 48% of UK fertility-clinic inspection non-compliances were classified as major in 2024/25.[31]
  • 224 Grade B incidents were reported by UK fertility clinics in 2024/25.[31]
  • 5% of UK fertility-clinic inspection non-compliances were classified as critical in 2024/25.[31]
  • 443 Grade C incidents were reported by UK fertility clinics in 2024/25.[31]
  • 792 incidents were reported to the HFEA by UK fertility clinics in 2024/25.[31]

Supply chain in the fertility clinic industry

  • 12%–15% of equipment value was the typical annual maintenance-contract cost used in a five-clinic IVF activity-based costing model.[5]
  • 16 medical-device field safety notices affecting fertility clinics were issued through the HFEA in 2023/24.[31]
  • 2 countries—the United States and Germany—were identified as manufacturing locations for all IVF Store supplies in a 2025 U.S. sector discussion.[4]
  • 12% was the weighted average cost of capital applied to IVF equipment and facility build-out in a five-clinic costing model.[5]
  • 5 fertility clinics contributed supply and equipment data to an IVF activity-based costing analysis.[5]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[39]
  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[39]
  • 54% of global healthcare providers used third-party providers for supply-chain services in 2024, based on a survey of 28 healthcare-provider executives.[39]
  • 20% of U.S. medical-group leaders planned to outsource or automate some revenue-cycle-management activities in 2024, according to an MGMA poll with 262 responses.[25]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[39]

11 Statistics

Finance & Pricing

The section frames clinic economics with profit ranges before and after acquisition for IVF-only services, including $2.36 million–$3.94 million pre-acquisition and $2.97 million–$4.96 million post-acquisition. It also documents an investor margin assumption of 37.5%.

Pricing strategy in the fertility clinic industry

  • $2.36 million–$3.94 million was the estimated annual pre-acquisition profit range for an average clinic based only on IVF services.[40]
  • $2.97 million–$4.96 million was the estimated annual post-acquisition profit range for an average clinic based only on IVF services.[40]
  • 30%–47.5% was the typical fertility-clinic profit-margin range reported by a chain investor interviewed in 2022.[40]
  • 37.5% was the static profit-margin assumption used to estimate the pricing and acquisition economics of U.S. fertility clinics.[18]
  • 25.8% was the estimated increase in IVF-cycle volume associated with chain ownership in the U.S. fertility-clinic study.[40]

Cost reduction in the fertility clinic industry

  • $2.1 million was Progyny’s employee-retention-credit refund benefit included in other general and administrative expenses in 2025.[41]
  • 8% was Progyny’s increase in cost of services in 2025 despite a 10% increase in revenue.[41]
  • $1.5 million was the decrease in Progyny stock-based compensation expense that partially offset higher personnel costs in 2025.[41]
  • $70.3 million was Progyny’s increase in cost of services in 2025 compared with 2024.[41]
  • $5.8 million was Progyny’s increase in personnel-related sales and marketing costs in 2025.[41]

Profitability in the fertility clinic industry

  • $304.484 million was Progyny’s gross profit in 2025.[41]
  • $6.532 million was INVO Fertility’s total revenue in fiscal 2024, including clinic, device and other reported segments.[42]
  • 23.6% was Progyny’s gross margin in 2025.[41]
  • $6.721 million was INVO Fertility’s fertility-clinic-services revenue in fiscal 2025.[43]
  • $2.4 million was the estimated average annual profit per U.S. fertility clinic before chain acquisition in the Management Science analysis.[18]

Financial planning in the fertility clinic industry

  • $660,000 was the principal balance of INVO Fertility convertible notes whose maturity was extended to December 31, 2026.[43]
  • $50,000 per month was the repayment amount INVO Fertility agreed to make on the JAG notes beginning in April 2026.[43]
  • $660,000 was the principal balance of INVO Fertility’s JAG notes before the May 2026 maturity extension.[43]
  • $3 million was the financing threshold above which INVO Fertility agreed to use 10% of excess proceeds to accelerate note repayment.[43]
  • 4 U.S. fertility clinics were operated by INVO Fertility as of the 2025 annual filing date.[43]

12 Statistics

Product & Service

It quantifies how AI is used in clinical work, including 86.3% of IVF specialists using AI for embryo selection. Outcome reporting includes 184,423 U.S. egg- or embryo-banking cycles in 2022.

Product development in the fertility clinic industry

  • 92.4% of surveyed IVF specialists said AI-assisted embryo annotation would help their work in 2022.[12]
  • 73.6% was the mean selection rate after embryologists received AI prediction highlights in a 2021 IVF study.[5]
  • 24.8% of surveyed IVF specialists reported using AI-based software in IVF in 2022, with embryo selection the leading application.[12]
  • 65.5% was the mean rate at which embryologists selected successfully implanted embryos before AI assistance in a 2021 IVF study.[5]
  • 86.3% of IVF specialists using AI reported applying it to embryo selection in 2022.[12]

Product lifecycle in the fertility clinic industry

  • 94,039 live-birth deliveries resulted from ART cycles at U.S. fertility clinics in 2022.[17]
  • 184,423 U.S. ART cycles were egg- or embryo-banking cycles in which all resulting eggs or embryos were frozen in 2022.[17]
  • 251,542 unique patients received ART at U.S. fertility clinics in 2022.[17]
  • 2.6% of infants born in the United States in 2022 resulted from ART cycles reported by fertility clinics.[17]
  • 435,426 ART cycles were performed at 457 U.S. fertility clinics in 2022.[17]

After-sales in the fertility clinic industry

  • 32% of comparable U.S. infertility patients who did not receive the reminder email returned to care in the same study.[5]
  • 62% of UK fertility patients were satisfied with the support provided, including access to counselling, in the 2021 survey.[31]
  • 31% of respondents who did not initially return to a U.S. infertility clinic said they were taking a break in the 2017–2018 study.[5]
  • 41% of U.S. infertility patients who received a compassionate reminder email returned to care after an initial visit in a 2017–2018 quality-improvement study.[5]
  • 72% of UK fertility patients were satisfied with their latest treatment experience in the 2021 national survey.[31]

Value proposition in the fertility clinic industry

  • 47% of UK fertility patients were satisfied with their experience of consulting a general practitioner before treatment in the 2021 survey.[31]
  • 87% of patients reported satisfaction with dignity and privacy at UK fertility clinics in the 2021 survey.[31]
  • 52% of UK fertility patients whose treatment was unsuccessful still viewed the overall process predominantly positively in the 2018 pilot survey.[31]
  • 78% of UK fertility patients spoke to a general practitioner before starting treatment in the 2021 survey.[31]
  • 30% of UK fertility patients whose treatment was unsuccessful were dissatisfied overall in the 2018 pilot survey.[31]

13 Statistics

Sustainability & Ethics

Waste and emissions are measured alongside donor-criteria reporting, including 396 grams of waste generated per frozen embryo transfer in a substituted cycle in the Netherlands. It also reports high shares with donor medical, mental-health, or lifestyle criteria.

Sustainability in the fertility clinic industry

  • 19 tonnes of CO2e were reported for Complete Fertility’s 2025 emissions, covering its Southampton clinic and two satellite clinics in England.[44]
  • 396 grams of waste were generated per frozen embryo transfer in a substituted cycle in the Netherlands, according to a 2026 study.[32]
  • 3,900 grams of waste were generated per IVF cycle in a Dutch observational study of fertility treatments in 2026.[32]
  • 7,034 kilograms of annual waste reduction were estimated for the Netherlands if identified fertility-treatment waste measures were adopted in 2026.[32]
  • 11% waste reduction for IUI and 22% for IVF were estimated through material-reduction measures in Dutch fertility treatment pathways in 2026.[32]

Ethics in the fertility clinic industry

  • 58% of 50 country respondents reported medical, mental-health or lifestyle criteria for embryo donors in the 2024 IFFS survey.[45]
  • 93.1% of 72 country respondents reported medical, mental-health or lifestyle criteria for oocyte donors in the 2024 IFFS survey.[45]
  • 90.2% of 72 country respondents reported medical, mental-health or lifestyle criteria for sperm donors in the 2024 IFFS survey.[45]
  • 29.0% of 69 country respondents said identifying donor information could be provided to offspring in the 2024 IFFS survey.[45]
  • 56.3% of 96 country respondents reported practices addressing donor anonymity in the 2024 IFFS survey.[45]

Circular economy in the fertility clinic industry

  • 870 grams of waste reduction per IVF or ICSI cycle were estimated from identified reuse and material-elimination measures in the Netherlands in 2026.[32]
  • 48% reduction in oocyte-retrieval waste was estimated through material-reduction measures in a Dutch IVF study in 2026.[32]
  • 402 grams of waste reduction over six IUI cycles were estimated from identified material-reduction measures in the Netherlands in 2026.[32]
  • 68% reduction in waste from the insemination procedure was achieved by removing or reusing selected materials in a Dutch fertility-treatment study in 2026.[32]
  • 38% reduction in embryo-transfer waste was estimated through material-reduction measures in a Dutch IVF study in 2026.[32]

Carbon footprint in the fertility clinic industry

  • 2.5 tonnes of Complete Fertility’s 2025 emissions were attributed to waste management in its Scope 3 inventory in England.[44]
  • 55,691 tonnes of CO2e were estimated from French assisted reproductive technology procedures in 2022, covering 30,963 ICSI and 15,674 IVF procedures.[32]
  • 2 tonnes of Scope 1 emissions were reported by Complete Fertility for 2025 across its Southampton clinic and two satellite clinics in England.[44]
  • 1.5 tonnes of Complete Fertility’s 2025 emissions were attributed to patient commuting in its Scope 3 inventory in England.[44]
  • 12 tonnes of Scope 3 emissions were reported by Complete Fertility for 2025 across its Southampton clinic and two satellite clinics in England.[44]

15 Statistics

Globalization & Expansion

Footprints and cross-border expansion show up as acquisition and geographic coverage, including FutureLife adding Italy through its Milano Fertility Clinic acquisition in 2025. It also reports multi-country footprints such as 75 clinics and 28 laboratories operated by IVI-RMA Global in 2022.

Globalization in the fertility clinic industry

  • One additional country, Italy, entered FutureLife’s Southern European footprint through its acquisition of Milano Fertility Clinic in 2025.[4]
  • 2.9 billion dollars was invested by private-equity firms across 30 global fertility-sector buyouts in 2023.[53]
  • 75 clinics and 28 laboratories operated across nine countries by IVI-RMA Global in 2022, according to the company’s reported footprint.[2]

Cultural adaptation in the fertility clinic industry

  • 77% of UK IVF patients were White, 15% Asian, 3% Black, 4% Other and 2% Mixed during 2017–2021.[31]
  • 64.5% of patients in two Kazakhstan assisted-reproduction clinics were recorded as Kazakh in a 2026 cultural-adaptation study.[24]
  • 92% of UK donor-insemination patients were White during 2017–2021, compared with 3% Asian, 2% Black, 2% Mixed and 1% Other.[31]

Stakeholder management in the fertility clinic industry

  • 79.1% of surveyed patients in the Kazakhstan study selected the maximum global patient-rating score of 10.[24]
  • 145 patients, or 53.3% of the recorded sample, attended Persona clinic and 127 patients, or 46.7%, attended IRM clinic in Kazakhstan.[24]
  • 272 patients and 74 staff members were included in a 2026 patient-centered fertility-care study covering two assisted-reproduction clinics in Kazakhstan.[24]
  • Nine geographically distributed UK clinics contributed 17,702 IVF/ICSI cycles to a 2005–2023 analysis of race and ethnicity reporting.[20]

Distribution channels in the fertility clinic industry

  • More than 650 fertility clinics and over 1,000 providers were included in Progyny’s U.S. network in 2024.[22]
  • 320,390 telehealth appointments were reported by Planned Parenthood organizations in 2025, illustrating a digital access channel for reproductive care.[54]
  • Over 30 fertility clinics and IVF laboratories were made available to Walmart employees through its fertility-treatment benefit announced in 2022.[2]
  • 110 million visits to PlannedParenthood.org were reported in 2025 as an online patient-information and service channel.[54]

Key questions about the Fertility Clinic Industry

What is the global fertility services market size in 2023?
The global fertility services market reached $42.2 billion in 2023.
How fast is the fertility clinic industry expected to grow through 2030?
The market is projected to grow at a 7.5% compound annual growth rate from 2024 to 2030. Grand View Research projects it to reach $52.7 billion in 2026 and $70.3 billion in 2030.
Which companies lead the fertility clinic industry?
US Fertility leads Gitnux's 2026 fertility clinic ranking with an Overall score of 9.8, with more than 135 clinic locations and 32 IVF laboratories. FutureLife is the runner-up at 9.5, backed by over 60 clinics in 15 European countries.
What technology shifts are most visible in fertility clinic operations?
Surveyed clinics report broad AI use: 74.9% in embryology laboratories and 75.4% in pretreatment activities. Administrative activities show AI use at 64.1%, alongside digital automation and trial evidence for tasks like vitrification and embryo selection.
How does market structure affect clinic performance in the United States?
U.S. chain affiliation increased from 5% in 2004 to 20% in 2018. A U.S. study covering 2004–2018 found acquired clinics increased IVF-cycle volume by 27.2% and improved live-birth rates by 13.6% after chain ownership.
What regulatory reporting requirements shape U.S. clinic data operations?
U.S. ART clinics must report standardized treatment and outcome data to the CDC under the Fertility Clinic Success Rate and Certification Act of 1992.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Min-ji Park. (2026, February 13). Fertility Clinic Industry Statistics. Gitnux. https://gitnux.org/fertility-clinic-industry-statistics
MLA
Min-ji Park. "Fertility Clinic Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/fertility-clinic-industry-statistics.
Chicago
Min-ji Park. 2026. "Fertility Clinic Industry Statistics." Gitnux. https://gitnux.org/fertility-clinic-industry-statistics.

Sources & references

67 sources cited across this report

  1. europeanfertilitysociety.com
  2. axios.com
  3. link.springer.com
  4. fertilitybridge.com
  5. pmc.ncbi.nlm.nih.gov
  6. deloitte.com
  7. healthit.gov
  8. business.adobe.com
  9. kpmg.com
  10. go.rackspace.com
  11. cetic.br
  12. jivfww.scholasticahq.com
  13. pubmed.ncbi.nlm.nih.gov
  14. arxiv.org
  15. carta.healthcare
  16. intersystems.com
  17. cdc.gov
  18. pubsonline.informs.org
  19. tennr.com
  20. fertstert.org
  21. griffin-jones.squarespace.com
  22. time.com
  23. pharmacy.umn.edu
  24. mdpi.com
  25. mgma.com
  26. wfhresearch.com
  27. pdfs.semanticscholar.org
  28. jbra.com.br
  29. pressganey.com
  30. journals.sagepub.com
  31. hfea.gov.uk
  32. academic.oup.com
  33. law.uh.edu
  34. fuelonline.com
  35. pewresearch.org
  36. sermo.com
  37. media.sproutsocial.com
  38. sciencedirect.com
  39. tcs.com
  40. investmentcouncil.org
  41. investors.progyny.com
  42. invofertility.com
  43. sec.gov
  44. completefertility.co.uk
  45. journals.lww.com
  46. ache.org
  47. ponemonsullivanreport.com
  48. proofpoint.com
  49. kff.org
  50. hfmmagazine.com
  51. england.nhs.uk
  52. sophos.com
  53. rbej.biomedcentral.com
  54. plannedparenthood.org
  55. grandviewresearch.com
  56. goodrx.com
  57. apnews.com
  58. usfertility.com
  59. futurelifegroup.com
  60. ivi-fertility.com
  61. virtushealth.com.au
  62. thefertilitypartners.com
  63. eugingroup.com
  64. novaivffertility.com
  65. birlafertility.com
  66. financialfilings.com
  67. indiraivf.com